Who Is Really at Risk for Anaphylaxis Due to COVID-19 Vaccine?
The vaccination campaign against the Severe acute respiratory syndrome coronavirus 2 (Sars-Cov-2) started on 8 December 2020 in UK, after the approval of BNT162b2 by the Healthcare products Regulatory Agency (MHRA) [...]
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI AG
2021-01-01
|
| Reeks: | Vaccines |
| Onderwerpen: | |
| Online toegang: | https://www.mdpi.com/2076-393X/9/1/38 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|